Rankings
▼
Calendar
ACRS Q4 2025 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ACRS
Aclaris Therapeutics, Inc.
$435M
Q4 2025 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$1M
-85.9% YoY
Gross Profit
$2M
162.0% margin
Operating Income
-$23M
-1755.5% margin
Net Income
-$20M
-1528.6% margin
EPS (Diluted)
$-0.16
QoQ Revenue Growth
-60.7%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$13M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$160M
Total Liabilities
$57M
Stockholders' Equity
$103M
Cash & Equivalents
$20M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1M
$9M
-85.9%
Gross Profit
$2M
-$90,000
+2431.1%
Operating Income
-$23M
-$100M
+77.2%
Net Income
-$20M
-$97M
+79.5%
Revenue Segments
License and Service
$795,000
61%
Contract research
$500,000
39%
← FY 2025
All Quarters